Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_210_библиотеки_им_акад_М_И_Перельмана
.pdf
331
215. Interdisciplinary European Guidelines on metabolic and bariatric surgery /
M. Fried, V. Yumuk, J.–M. Oppert [et al.] // Obesity Facts. – 2013. – Vol. 6, N 5. –
P.449–468.
216. Intestinal methane production in obese individuals is associated with a
higher body mass index / R.J. Basseri, B. Basseri, M. Pimentel [et al.] //
Gastroenterology & Hepatology. – 2012. – Vol. 8, N 1. – P.22–28.
217. Intestinal microbiota in functional bowel disorders: a Rome foundation
report / M. Simrén, G. Barbara, H.J. Flint [et al.] // Gut. – 2013. – Vol. 62, N 1. –
P.159–176.
218. Involvement of gut microbiota in the development of low–grade
inflammation and type 2 diabetes associated with obesity / P.D. Cani, M. Osto, L.
Geurts, A. Everard // Gut Microbes. – 2012. – Vol. 3, N 4. – P.279–288.
219. Irritable bowel syndrome–like symptoms and health related quality of life
two years after Roux–en–Y gastric bypass – a prospective cohort study / I.K. Blom–
Høgestøl, M. Aasbrenn, M. Chahal–Kummen [et al.] // BMC gastroenterology. – 2019.
– Vol. 19, N 1. – P.204.
220. Is weight regain after bariatric surgery associated with psychiatric
comorbidity? A systematic review and meta–analysis / M.F.F.P. Mauro, M. Papelbaum,
M.A.A. Brasil [et al.] // Obesity Reviews. – 2019. – Vol. 20, N 10. – P.1413–1425.
221. Johnson, D.A. Gastroenterologic Issues in the Obese Patient / D.A. Johnson
// Gastroenterol Clin North Am. – 2010. – 39(1). – 169 p.
222. Johnson, L.F. Twenty–four–hour pH monitoring of the distal esophagus. A
quantitative measure of gastroesophageal reflux / L.F. Johnson, T.R. Demeester // The
American Journal of Gastroenterology. – 1974. – Vol. 62, N 4. – P.325–332.
223. Kalueff, A.V. Role of GABA in anxiety and depression / A.V. Kalueff,
D.J. Nutt // Depression and Anxiety. – 2007. – Vol. 24, N 7. – P.495–517.
224. Katzka, D.A. Phenotypes of Gastroesophageal Reflux Disease: Where
Rome, Lyon, and Montreal Meet / D.A. Katzka, J.E. Pandolfino, P.J. Kahrilas // Clinical
Gastroenterology and Hepatology. – 2020. – Vol. 18, N 4. – P.767–776.
https://t.me/med1917
332
225. Kendrick, M.L. Gastroesophageal reflux disease in obese patients: the role
of obesity in management / M.L. Kendrick, S.G. Houghton // Diseases of the
Esophagus. – 2006. – Vol. 19, N 2. – P.57–63.
226. King, P.J. The hypothalamus and obesity / P.J. King // Current Drug
Targets. – 2005. – Vol. 6, N 2. – P.225–240.
227. Kovacic, K. Current concepts in functional gastrointestinal disorders / K.
Kovacic // Current Opinion in Pediatrics. – 2015. – Vol. 27, N 5. – P.619–624.
228. Koyyada, A. Long–term use of proton pump inhibitors as a risk factor for
various adverse manifestations / A. Koyyada // Therapie. – 2021. – Vol. 76, N 1. –
P.13–21.
229. Krysiak, R. The role of adipokines in connective tissue diseases / R.
Krysiak, G. Handzlik–Orlik, B. Okopien // European Journal of Nutrition. – 2012. –
Vol. 51, N 5. – P.513–528.
230. Kusnanto, H. Biopsychosocial model of illnesses in primary care: A
hermeneutic literature review / H. Kusnanto, D. Agustian, D. Hilmanto // Journal of
Family Medicine and Primary Care. – 2018. – Vol. 7, N 3. – P.497–500.
231. Lactobacillus fermentum promotes adipose tissue oxidative
phosphorylation to protect against diet–induced obesity / Y. Yoon, G. Kim, M.–G. Noh
[et al.] // Experimental & Molecular Medicine. – 2020. – Vol. 52, N 9. – P.1574–1586.
232. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat
Accumulation and Waist Circumference in Obese Adults: A Randomized, Double–
Blind, Placebo–Controlled Trial / J. Kim, J.M. Yun, M.K. Kim [et al.] // Journal of
Medicinal Food. – 2018. – Vol. 21, N 5. – P.454–461.
233. Laparoscopic sleeve gastrectomy and gastroesophageal reflux / A.–L.
Popescu, F. Ioniţa–Radu, M. Jinga [et al.] // Romanian Journal of Internal Medicine =
Revue Roumaine De Medecine Interne. – 2018. – Vol. 56, N 4. – P.227–232.
234. Lee, Y.Y. Disruption of the gastroesophageal junction by central obesity
and waist belt: role of raised intra–abdominal pressure / Y.Y. Lee, K.E.L. McColl //
Diseases of the Esophagus. – 2015. – Vol. 28, N 4. – P.318–325.
https://t.me/med1917
333
235. Lifestyle weight–loss intervention outcomes in overweight and obese
adults with type 2 diabetes: a systematic review and meta–analysis of randomized
clinical trials / M.J. Franz, J.L. Boucher, S. Rutten–Ramos, J. J. VanWormer // Journal
of the Academy of Nutrition and Dietetics. – 2015. – Vol. 115, N 9. – P.1447–1463.
236. Long–chain saturated fatty acids consumption and risk of gallstone disease
among men / C.–J. Tsai, M.F. Leitzmann, W.C. Willett, E.L. Giovannucci // Annals of
Surgery. – 2008. – Vol. 247, N 1. – P.95–103.
237. Macfarlane, S. Microbial biofilms in the human gastrointestinal tract / S.
Macfarlane, J. F. Dillon // Journal of Applied Microbiology. – 2007. – Vol. 102, N 5. –
P.1187–1196.
238. MAFLD: A Consensus–Driven Proposed Nomenclature for Metabolic
Associated Fatty Liver Disease / M. Eslam, A. J. Sanyal, J. George, International
Consensus Panel // Gastroenterology. – 2020. – Vol. 158, N 7. – P.1999–2014.e1.
239. Malbert, C.-H. The ileocolonic sphincter / C.-H. Malbert //
Neurogastroenterology and Motility. – 2005. – Vol. 17, Suppl 1. – P.41–49.
240. Martin, A.M. Mechanisms controlling hormone secretion in human gut and
its relevance to metabolism / A.M. Martin, E.W. Sun, D.J. Keating // The Journal of
Endocrinology. – 2019. – Vol. 244, N 1. – P.R1–R15.
241. Measuring physical impairment and disability with the Chedoke–McMaster
Stroke Assessment / C. Gowland, P. Stratford, M. Ward [et al.] // Stroke. – 1993. – Vol.
24, N 1. – P.58–63.
242. Mermelstein, J. Proton pump inhibitor–refractory gastroesophageal reflux
disease: challenges and solutions / J. Mermelstein, A. Chait Mermelstein, M.M. Chait //
Clinical and Experimental Gastroenterology. – 2018. – Vol. 11, P.119–134.
243. Meta–analysis of the efficacy of psychological and medical treatments for
binge–eating disorder / A. Hilbert, D. Petroff, S. Herpertz [et al.] // Journal of
Consulting and Clinical Psychology. – 2019. – Vol. 87, N 1. – P.91–105.
244. Metabolic and body composition factors in subgroups of obesity: what do
we know? / A.D. Karelis, D.H. St–Pierre, F. Conus [et al.] // The Journal of Clinical
Endocrinology and Metabolism. – 2004. – Vol. 89, N 6. – P.2569–2575.
https://t.me/med1917
334
245. Metabolic and Microbial Changes Associated With Diet and Obesity
During Pregnancy: What Can We Learn From Animal Studies? / C. Dreisbach, H.
Morgan, C. Cochran [et al.] // Frontiers in Cellular and Infection Microbiology. – 2021.
– Vol. 11. –– P.795924.
246. Metabolic biomarkers and gallstone disease – a population–based study /
D. M. Shabanzadeh, T. Skaaby, L.T. Sørensen [et al.] // Scandinavian Journal of
Gastroenterology. – 2017. – Vol. 52, N 11. – P.1270–1277.
247. Metabolic risk factors and incident advanced liver disease in non–alcoholic
fatty liver disease (NAFLD): A systematic review and meta–analysis of population–
based observational studies / H. Jarvis, D. Craig, R. Barker [et al.] // PLoS medicine. –
2020. – Vol. 17, N 4. – P.e1003100.
248. Metabolically healthy obesity: epidemiology, mechanisms, and clinical
implications / N. Stefan, H.–U. Häring, F.B. Hu, M.B. Schulze // The Lancet. Diabetes
& Endocrinology. – 2013. – Vol. 1, N 2. – P.152–162.
249. Microbial ecology: human gut microbes associated with obesity / R.E. Ley,
P.J. Turnbaugh, S. Klein, J.I. Gordon // Nature. – 2006. – Vol. 444, N 7122. – P.1022–
1023.
250. Microbial genes and pathways in inflammatory bowel disease / M.
Schirmer, A. Garner, H. Vlamakis, R.J. Xavier // Nature Reviews. Microbiology. –
2019. – Vol. 17, N 8. – P.497–511.
251. Microbiota in obesity: interactions with enteroendocrine, immune and
central nervous systems / R.J. Mulders, K.C.G. de Git, E. Schéle [et al.] // Obesity
Reviews. – 2018. – Vol. 19, N 4. – P.435–451.
252. Mikami, D. J. Physiology and pathogenesis of gastroesophageal reflux
disease / D.J. Mikami, K.M. Murayama // The Surgical Clinics of North America. –
2015. – Vol. 95, N 3. – P.515–525.
253. Mishra, T. Prevalence of Cholelithiasis and Choledocholithiasis in
Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus
Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass / T.Mishra,
K.K. Lakshmi, K.K. Peddi // Obesity Surgery. – 2016. – Vol. 26, N 10. – P.2411–2417.
https://t.me/med1917
335
254. Modern diagnosis of GERD: the Lyon Consensus / C.P. Gyawali, P.J.
Kahrilas, E. Savarino [et al.] // Gut. – 2018. – Vol. 67, N 7. – P.1351–1362.
255. Modulation of the murine microbiome with a concomitant anti–obesity
effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28 / Y.S. Ji, H.N.
Kim, H.J. Park [et al.] // Beneficial Microbes. – 2012. – Vol. 3, N 1. – P.13–22.
256. Molecular characterisation of the faecal microbiota in patients with type II
diabetes / X. Wu, C. Ma, L. Han [et al.] // Current Microbiology. – 2010. – Vol. 61, N
1. – P.69–78.
257. Morabia, A. The WHO report «Preventing chronic diseases: a vital
investment» and us / A. Morabia, T. Abel // Sozial– Und Praventivmedizin. – 2006. –
Vol. 51, N 2. – P.74.
258. Mulak, A. The impact of probiotics on interactions within the microbiota–
gut–lung triad in COVID–19 / A. Mulak // International Journal of Food Sciences and
Nutrition. – 2021. – Vol. 72, N 4. – P.577–578.
259. Nam, S.Y. Obesity–Related Digestive Diseases and Their Pathophysiology
/ S.Y. Nam // Gut and Liver. – 2017. – Vol. 11, N 3. – P.323–334.
260. Nauck, M.A. Incretin hormones: Their role in health and disease / M.A.
Nauck, J.J. Meier // Diabetes, Obesity & Metabolism. – 2018. – Vol. 20, Suppl 1. – P.5–
21.
261. NCD Risk Factor Collaboration (NCD–RisC). Trends in adult body–mass
index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population–based
measurement studies with 19·2 million participants / NCD Risk Factor Collaboration
(NCD–RisC) // Lancet (London, England). – 2016. – Vol. 387, N 10026. – P.1377–
1396.
262. Nebel, O.T. Lower esophageal sphincter pressure changes after food
ingestion / O.T. Nebel, D.O. Castell // Gastroenterology. – 1972. – Vol. 63, N 5. –
P.778–783.
263. Neither low–calorie diet nor vertical banded gastroplasty influence gastro–
oesophageal reflux in morbidly obese patients / S.G. Frederiksen, J. Johansson, F.
https://t.me/med1917
336
Johnsson, J. Hedenbro // The European Journal of Surgery = Acta Chirurgica. – 2000. –
Vol. 166, N 4. – P.296–300.
264. Neuroimaging and neuromodulation approaches to study eating behavior
and prevent and treat eating disorders and obesity / D. Val–Laillet, E. Aarts, B. Weber
[et al.] // NeuroImage. Clinical. – 2015. – Vol. 8. – P.1–31.
265. Non–Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the
Fifth Component of Metabolic Syndrome? A Literature Review / B.S. Romana, H.
Chela, F.E. Dailey [et al.] // Endocrine, Metabolic & Immune Disorders Drug Targets. –
2018. – Vol. 18, N 6. – P.547–554.
266. Null, G. Diet and lifestyle intervention on chronic moderate to severe
depression and anxiety and other chronic conditions / G. Null, L. Pennesi //
Complementary Therapies in Clinical Practice. – 2017. – Vol. 29. – P.189–193.
267. Obesity and the gut microbiota: does up–regulating colonic fermentation
protect against obesity and metabolic disease? / L. Conterno, F. Fava, R. Viola, K. M.
Tuohy // Genes & Nutrition. – 2011. – Vol. 6, N 3. – P.241–260.
268. Obesity in adults: a clinical practice guideline / S. Wharton, D.C.W. Lau,
M. Vallis [et al.] // CMAJ: Canadian Medical Association journal. – 2020. – Vol. 192,
N 31. – P.E875–E891.
269. Obesity increases oesophageal acid exposure / H.B. El–Serag, G.A. Ergun,
J. Pandolfino [et al.] // Gut. – 2007. – Vol. 56, N 6. – P.749–755.
270. Obesity Is Inversely Related to Hydrogen–Producing Small Intestinal
Bacterial Overgrowth in Non–Constipation Irritable Bowel Syndrome / S.E. Jung, N.S.
Joo, K.S. Han, K.N. Kim // Journal of Korean Medical Science. – 2017. – Vol. 32, N 6.
– P.948–953.
271. On the validity of the Beck Depression Inventory. A review / P. Richter, J.
Werner, A. Heerlein [et al.] // Psychopathology. – 1998. – Vol. 31, N 3. – P.160–168.
272. Optimal cut–off values for the homeostasis model assessment of insulin
resistance (HOMA–IR) and pre–diabetes screening: Developments in research and
prospects for the future / Q. Tang, X. Li, P. Song, L. Xu // Drug Discoveries &
Therapeutics. – 2015. – Vol. 9, N 6. – P.380–385.
https://t.me/med1917
337
273. Oshima, T. Epidemiology of Functional Gastrointestinal Disorders in Japan
and in the World / T. Oshima, H. Miwa // Journal of Neurogastroenterology and
Motility. – 2015. – Vol. 21, N 3. – P.320–329.
274. Park, S. Probiotics for weight loss: a systematic review and meta–analysis /
S. Park, J.–H. Bae // Nutrition Research (New York, N.Y.). – 2015. – Vol. 35, N 7. –
P.566–575.
275. Patterns of gastroesophageal reflux in health and disease / T.R. Demeester,
L.F. Johnson, G.J. Joseph [et al.] // Annals of Surgery. – 1976. – Vol. 184, N 4. –
P.459–470.
276. Persistent and De Novo GERD After Sleeve Gastrectomy: Manometric and
pH–Impedance Study Findings / L. Poggi, G.M. Bernui, D.A. Romani [et al.] // Obesity
Surgery. – 2023. – Vol. 33, N 1. – P.87–93.
277. Pessentheiner, A.R. Proteoglycans in Obesity–Associated Metabolic
Dysfunction and Meta–Inflammation / A.R. Pessentheiner, G. M. Ducasa, P. L. S. M.
Gordts // Frontiers in Immunology. – 2020. – Vol. 11. – P.769.
278. Polyzos, S.A. Adipose tissue, obesity and non–alcoholic fatty liver disease
/ S.A. Polyzos, J. Kountouras, C.S. Mantzoros // Minerva Endocrinologica. – 2017. –
Vol. 42, N 2. – P.92–108.
279. Preoperative high–resolution esophageal manometry and postoperative
symptoms in patients undergoing bariatric surgery: a retrospective cohort study / K.
Dalal, B. White, J. Gaughan, J. DeSipio // Surgery for Obesity and Related Diseases. –
2022. – Vol. 18, N 1. – P.85–94.
280. Prevalence of Gastroesophageal Reflux Disease and Proton Pump
Inhibitor–Refractory Symptoms / S.D. Delshad, C.V. Almario, W.D. Chey, B.M.R.
Spiegel // Gastroenterology. – 2020. – Vol. 158, N 5. – P.1250–1261.e2.
281. Prevalence of gastroesophageal reflux disease in Moscow / S. Bor, L.B.
Lazebnik, G. Kitapcioglu [et al.] // Diseases of the Esophagus. – 2016. – Vol. 29, N 2. –
P.159–165.
https://t.me/med1917
338
282. Probiotic Strains and Intervention Total Doses for Modulating Obesity–
Related Microbiota Dysbiosis: A Systematic Review and Meta–analysis / A. López–
Moreno, A. Suárez, C. Avanzi [et al.] // Nutrients. – 2020. – Vol. 12, N 7. – P.E1921.
283. Production of gamma–aminobutyric acid by Lactobacillus brevis NCL912
using fed–batch fermentation / H.Li, T. Qiu, G. Huang, Y. Cao // Microbial Cell
Factories. – 2010. – Vol. 9, P.85.
284. Prolonged transfer of feces from the lean mice modulates gut microbiota in
obese mice / M. Kulecka, A. Paziewska, N. Zeber–Lubecka [et al.] // Nutrition &
Metabolism. – 2016. – Vol. 13, N 1. – P.57.
285. Prospective study of colorectal cancer risk in men and plasma levels of
insulin–like growth factor (IGF)–I and IGF–binding protein–3 / J. Ma, M.N. Pollak, E.
Giovannucci [et al.] // Journal of the National Cancer Institute. – 1999. – Vol. 91, N 7. –
P.620–625.
286. Proton pump inhibitor resistance, the real challenge in gastro–esophageal
reflux disease / M. Cicala, S. Emerenziani, M.P.L. Guarino, M. Ribolsi // World Journal
of Gastroenterology. – 2013. – Vol. 19, N 39. – P.6529–6535.
287. Quantitative insulin sensitivity check index: a simple, accurate method for
assessing insulin sensitivity in humans / A. Katz, S.S. Nambi, K. Mather [et al.] // The
Journal of Clinical Endocrinology and Metabolism. – 2000. – Vol. 85, N 7. – P.2402–
2410.
288. Rabeprazole 10 mg versus 20 mg in preventing relapse of gastroesophageal
reflux disease: a meta–analysis / H. Zhu, H. Wang, X. Xia [et al.] // Chinese Medical
Journal. – 2013. – Vol. 126, N 16. – P.3146–3150.
289. Ramezani–Jolfaie, N. Effects of a healthy Nordic diet on weight loss in
adults: a systematic review and meta–analysis of randomized controlled clinical trials /
N. Ramezani–Jolfaie, M. Mohammadi, A. Salehi–Abargouei // Eating and weight
disorders. – 2020. – Vol. 25, N 5. – P.1141–1150.
290. Randomised clinical trial: gabapentin vs baclofen in the treatment of
suspected refractory gastro–oesophageal reflux–induced chronic cough / R. Dong, X.
https://t.me/med1917
339
Xu, L. Yu [et al.] // Alimentary Pharmacology & Therapeutics. – 2019. – Vol. 49, N 6.
– P.714–722.
291. Randomised clinical trial: the effectiveness of Gaviscon Advance vs non–
alginate antacid in suppression of acid pocket and post–prandial reflux in obese
individuals after late–night supper / M.A. Deraman, M.I. Abdul Hafidz, R.M. Lawenko
[et al.] // Alimentary Pharmacology & Therapeutics. – 2020. – Vol. 51, N 11. – P.1014–
1021.
292. Recent progress in genetics, epigenetics and metagenomics unveils the
pathophysiology of human obesity / M. Pigeyre, F.T. Yazdi, Y. Kaur, D. Meyre //
Clinical. – 2016. – Vol. 130, N 12. – P.943–986.
293. Recombinant Lactococcus lactis NZ3900 expressing bioactive human
FGF21 reduced body weight of Db/Db mice through the activity of brown adipose
tissue / W.–Y. Cao, M. Dong, Z.–Y. Hu [et al.] // Beneficial Microbes. – 2020. – Vol.
11, N 1. – P.67–78.
294. Recombinant Mouse Osteocalcin Secreted by Lactococcus lactis Promotes
Glucagon–Like Peptide–1 Induction in STC–1 Cells / F. Namai, S. Shigemori, K. Sudo
[et al.] // Current Microbiology. – 2018. – Vol. 75, N 1. – P.92–98.
295. Recurrence of gastroesophageal reflux disease correlated with a short
dinner–to–bedtime interval / J.H. Yang, H.S. Kang, S.–Y. Lee [et al.] // Journal of
Gastroenterology and Hepatology. – 2014. – Vol. 29, N 4. – P.730–735.
296. Relationship Between Bariatric Surgery and Gastroesophageal Reflux
Disease: a Systematic Review and Meta–analysis / L. Gu, B. Chen, N. Du [et al.] //
Obesity Surgery. – 2019. – Vol. 29, N 12. – P.4105–4113.
297. Relationship between body mass index, diet, exercise and gastro–
oesophageal reflux symptoms in a community / S. Nandurkar, G.R. Locke, S. Fett [et
al.] // Alimentary Pharmacology & Therapeutics. – 2004. – Vol. 20, N 5. – P.497–505.
298. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity
/ A. Gasmi, P.K. Mujawdiya, L. Pivina [et al.] // Current Medicinal Chemistry. – 2021.
– Vol. 28, N 4. – P.827–839.
https://t.me/med1917
340
299. Reliability and validity of the Gastrointestinal Symptom Rating Scale
(GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in
dyspepsia: a six–country study / K.R. Kulich, A. Madisch, F. Pacini [et al.] // Health
and Quality of Life Outcomes. – 2008. – Vol. 6. – P.12.
300. Rhee, S.H. Principles and clinical implications of the brain–gut–enteric
microbiota axis / S.H. Rhee, C. Pothoulakis, E.A. Mayer // Nature Reviews.
Gastroenterology & Hepatology. – 2009. – Vol. 6, N 5. – P.306–314.
301. Richness of human gut microbiome correlates with metabolic markers / E.
Le Chatelier, T. Nielsen, J. Qin [et al.] // Nature. – 2013. – Vol. 500, N 7464. – P.541–
546.
302. Richter, J.E. Presentation and Epidemiology of Gastroesophageal Reflux
Disease / J.E. Richter, J.H. Rubenstein // Gastroenterology. – 2018. – Vol. 154, N 2. –
P.267–276.
303. Risk of GERD–Related Disorders in Obese Patients on PPI Therapy: a
Population Analysis / S. Erridge, O.M. Moussa, P. Ziprin [et al.] // Obesity Surgery. –
2018. – Vol. 28, N 9. – P.2796–2803.
304. Role of gut microbiota via the gut–liver–brain axis in digestive diseases /
J.–H. Ding, Z. Jin, X.–X. Yang [et al.] // World Journal of Gastroenterology. – 2020. –
Vol. 26, N 40. – P.6141–6162.
305. Ruhl C.E. Overweight, but not high dietary fat intake, increases risk of
gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic
Followup Study. First National Health and Nutrition Examination Survey / C.E. Ruhl,
J.E. Everhart // Annals of Epidemiology. – 1999. – Vol. 9, N 7. – P.424–435.
306. Ryan, D.H. Guidelines for Obesity Management / D.H. Ryan //
Endocrinology and Metabolism Clinics of North America. – 2016. – Vol. 45, N 3. –
P.501–510.
307. Ryan, D.H. Guideline Recommendations for Obesity Management / D.H.
Ryan, S. Kahan // The Medical Clinics of North America. – 2018. – Vol. 102, N 1. –
P.49–63.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана